irinotecan,leucovorin,oxaliplatin,nab-paclitaxel,gemcitabine
Ipsen
[]
the #oncoalerttoptweet day2 of #gi23 tweet #napoli3 dr. wainberg in #1l metastatic #pdac #nalirifox shows median os benefit over gem/abrax 11.1 vs 9.2 mos w/orr 41.8 vs 36.2%. new reference regiment in 1l met #pancsm best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨